Is RGNX a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Regenxbio Inc (RGNX) is (154.85) USD. With the latest stock price at 8.50 USD, the upside of Regenxbio Inc based on DCF is -1921.7%. This means that RGNX is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.8% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (427.03) - (96.72) | (154.85) |
| Upside | -5123.9% - -1237.9% | -1921.7% |